| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/30/2002 | WO2002026371A3 Apparatus and method for preparing microparticles using liquid-liquid extraction |
| 05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 05/30/2002 | WO2002009669A3 Apparatus and process to produce particles having a narrow size distribution and particles made thereby |
| 05/30/2002 | WO2001097778A3 Amphotericin b structured emulsion |
| 05/30/2002 | WO2001097775A3 Controlled release anti-inflammatory formulation |
| 05/30/2002 | WO2001092580A3 Lyophilizable and enhanced compacted nucleic acids |
| 05/30/2002 | WO2001091724A3 Transdermal delivery of lasofoxifene |
| 05/30/2002 | WO2001091721A3 Modified starch as a replacement for gelatin in soft gel films and capsules |
| 05/30/2002 | WO2001089495A3 Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
| 05/30/2002 | WO2001087913A3 Method for treating retinal degeneration with purinergic receptor agonists |
| 05/30/2002 | WO2001083520A3 Polyacid glycopeptide derivatives |
| 05/30/2002 | WO2001078683A3 Sustained release formulations comprising growth hormone |
| 05/30/2002 | WO2001074431A3 Dispensing devices and liquid formulations |
| 05/30/2002 | WO2001074390A3 The use of a calcium channel blocker for treating renal disorders |
| 05/30/2002 | WO2001060278A3 Oral therapeutic delivery appliance |
| 05/30/2002 | WO2001050994A8 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 05/30/2002 | WO2001045731A9 Particulate drug-containing products and method of manufacture |
| 05/30/2002 | WO2001041741A9 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 05/30/2002 | WO2001035867A8 Ophthalmologic implant |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | WO2000060953A3 Methods for stabilizing liquid nutritional products and products so stabilized |
| 05/30/2002 | WO2000051567A8 Processes for making pharmaceutical oral ecb formulations and compositions |
| 05/30/2002 | WO2000051564A8 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 05/30/2002 | US20020065540 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 05/30/2002 | US20020065509 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 05/30/2002 | US20020065506 Epidural administration of therapeutic compounds with sustained rate of release |
| 05/30/2002 | US20020065479 Apparatus and methods for dispensing pet care substances |
| 05/30/2002 | US20020065454 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 05/30/2002 | US20020065411 Starch |
| 05/30/2002 | US20020065399 Aerosolized polypeptide for use in treatment of lung disorders lungs |
| 05/30/2002 | US20020065329 Hydrogel |
| 05/30/2002 | US20020065326 Patient oxygenation using stabilized fluorocarbon emulsions |
| 05/30/2002 | US20020065321 Nasal administration of agents for the treatment of gastroparesis |
| 05/30/2002 | US20020065301 Paroxetine compositions and processes for making the same |
| 05/30/2002 | US20020065281 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 05/30/2002 | US20020065280 Oxazolidinones to treat eye infections |
| 05/30/2002 | US20020065263 Formulation |
| 05/30/2002 | US20020065256 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 05/30/2002 | US20020065255 Disodium salt of active delivery agents (drugs) form solvates with ethanol and hydrates with water; greater efficacy for delivering active agents than monosodium salt |
| 05/30/2002 | US20020065233 Oral administration of Sulodexide in unit dosages suitable for the treatment of diabetic nephropathies in both macro and micro albuminic patients, producing immediate and lasting improvement in albumin excretion rate |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064858 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 05/30/2002 | US20020064571 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis. |
| 05/30/2002 | US20020064566 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 05/30/2002 | US20020064563 Core particles which are coated with a taste mask coating to provide coated particles which can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules |
| 05/30/2002 | US20020064562 Granulates compacted together into a tablet form together with an extra-granular lubricant; especially amoxycillin plus clavulanic acid, and crosslinked polyvinylpyrrolidone or sodium starch glycolate intra-granular disintegrant |
| 05/30/2002 | US20020064561 Quick release compositions |
| 05/30/2002 | US20020064560 Hydrophobic and/or hydrophilic active agents and a polymeric emulsifier. |
| 05/30/2002 | US20020064559 Such as by repeated compression; drug or combination of drugs is reversably bound to matrix; makes possible delivery of drug directly to site of wound or trauma in vivo |
| 05/30/2002 | US20020064557 Microencapsulation and sustained release of oligonucleotides |
| 05/30/2002 | US20020064556 Core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane. |
| 05/30/2002 | US20020064555 Proton pump inhibitor formulation |
| 05/30/2002 | US20020064554 Radiation sensitive liposomes |
| 05/30/2002 | US20020064553 Large liposome composition not increasing ldl levels and method of treating atherosclerosis related thereto |
| 05/30/2002 | US20020064549 Insulin supplemented infant formula |
| 05/30/2002 | US20020064547 Liquid polymeric compositions for controlled release of bioactive substances |
| 05/30/2002 | US20020064546 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 05/30/2002 | US20020064541 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064520 Targeted artificial gene delivery |
| 05/30/2002 | US20020064516 Pharmaceutical compositions comprising TGF-beta |
| 05/30/2002 | US20020064514 Preparing material which comprises ionic polysaccharide and block polymer; placing material in contact with biological tissue; cross-linking to form gel |
| 05/30/2002 | US20020064513 For therapy of eye infections such as conjunctivitis, blepharitis, keratitis sicca etc and to provide intraocular treatment through the cornea for diseases such as glaucoma or uveitis |
| 05/30/2002 | US20020064512 May be used for medical indications, such as an implantable or injectable endoprostheses for mammoplastic reconstruction, implantable or injectable endoprostheses for treating (reflux) oesophagitis, and for body contouring of various body parts |
| 05/30/2002 | US20020064505 Oral anti-odor compositions |
| 05/30/2002 | US20020064503 Administering dose of mixture of lipid crystals comprising surfactant and spreading agnet as aerosol through an external airway of a mammal for enhancing mammalian eustachian tube lumen patency and pressure equalization performance |
| 05/30/2002 | CA2541946A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | CA2432804A1 Porous polymeric biomaterials, preparation method and uses |
| 05/30/2002 | CA2431947A1 Composition comprising an imexon or derivatives thereof and lipids |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429516A1 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation |
| 05/30/2002 | CA2429310A1 Repinotan kit |
| 05/30/2002 | CA2429254A1 Oral nanosphere delivery |
| 05/30/2002 | CA2427340A1 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | CA2427330A1 Inhibitors of abc drug transporters at the blood-brain barrier |
| 05/29/2002 | EP1209097A1 Packaging bag for plaster and packaged plaster |
| 05/29/2002 | EP1208851A2 A medicament for pulmonary drug delivery |
| 05/29/2002 | EP1208850A1 Pastes with the sustained release of osteogenesis promoter |
| 05/29/2002 | EP1208847A2 Pharmaceutical compositions for treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-O(2-hydroxyethyl)-rapamycin |
| 05/29/2002 | EP1208844A1 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 05/29/2002 | EP1208843A1 Soft capsules |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208838A2 Pure S(+)isomer fluoxetine |
| 05/29/2002 | EP1208242A1 Antisense modulation of pepck-mitochondrial expression |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208212A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208143A1 Film coatings and film coating compositions based on polyvinyl alcohol |
| 05/29/2002 | EP1208140A1 Rapidly decomposing chitosan-based pellets |
| 05/29/2002 | EP1208139A1 Method of producing an absorbent foam material |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208086A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 05/29/2002 | EP1208005A1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 05/29/2002 | EP1207936A1 Iontophoretic drug delivery device and reservoir and method of making same |
| 05/29/2002 | EP1207912A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/29/2002 | EP1207910A2 Improved container composition for diagnostic agents |
| 05/29/2002 | EP1207908A1 Method of treating body insect infestation |